Summit Pharmaceuticals facilitates strategic and
commercial relationships between U.S. and Japanese
life science companies, arranging licensing,
production, and import and export of new drugs and
diagnostic products. They produce chemicals and
compounds required to manufacture drugs, as well as
manufacture finished biologic products. They also invest in
select mid- to late-stage
pharmaceutical companies. With more than 60 clients in Japan, Summit Pharmaceuticals' major accounts include Bristol-Myers Squibb, Abbott Laboratories, GlaxoSmithKline, Johnson & Johnson and Pfizer.
www.summitpharma.co.jp/english/
